Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 167

Similar articles for PubMed (Select 21945954)

1.

Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.

Satoskar AA, Efebera Y, Hasan A, Brodsky S, Nadasdy G, Dogan A, Nadasdy T.

Am J Surg Pathol. 2011 Nov;35(11):1685-90. doi: 10.1097/PAS.0b013e3182263d74.

2.

Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue.

Klein CJ, Vrana JA, Theis JD, Dyck PJ, Dyck PJ, Spinner RJ, Mauermann ML, Bergen HR 3rd, Zeldenrust SR, Dogan A.

Arch Neurol. 2011 Feb;68(2):195-9. doi: 10.1001/archneurol.2010.261. Epub 2010 Oct 11.

3.

Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production.

Laeng RH, Altermatt HJ, Scheithauer BW, Zimmermann DR.

Cancer. 1998 Jan 15;82(2):362-74.

PMID:
9445195
4.

Relationship between monoclonal gammopathy and cardiac amyloid type.

Maleszewski JJ, Murray DL, Dispenzieri A, Grogan M, Pereira NL, Jenkins SM, Judge DP, Caturegli P, Vrana JA, Theis JD, Dogan A, Halushka MK.

Cardiovasc Pathol. 2013 May-Jun;22(3):189-94. doi: 10.1016/j.carpath.2012.09.001. Epub 2012 Oct 24.

PMID:
23102805
5.

[Amyloidosis in liver biopsies].

Gioeva Z, Kieninger B, Röcken C.

Pathologe. 2009 May;30(3):240-5. doi: 10.1007/s00292-009-1133-4. German.

PMID:
19415368
6.

Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry.

Olson LJ, Gertz MA, Edwards WD, Li CY, Pellikka PA, Holmes DR Jr, Tajik AJ, Kyle RA.

N Engl J Med. 1987 Sep 17;317(12):738-42.

PMID:
3627183
7.

[Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].

Arbustini E, Gavazzi A, Merlini G.

Ital Heart J Suppl. 2002 Jun;3(6):590-7. Review. Italian.

PMID:
12116807
8.

The premortem recognition of systemic senile amyloidosis with cardiac involvement.

Kyle RA, Spittell PC, Gertz MA, Li CY, Edwards WD, Olson LJ, Thibodeau SN.

Am J Med. 1996 Oct;101(4):395-400.

PMID:
8873510
9.

Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.

Gouvêa AF, Ribeiro AC, León JE, Carlos R, de Almeida OP, Lopes MA.

J Oral Pathol Med. 2012 Feb;41(2):178-85. doi: 10.1111/j.1600-0714.2011.01073.x. Epub 2011 Aug 29.

PMID:
21883489
10.

Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type.

Löfberg H, Thysell H, Westman K, Larsen S, Brun C, Gruic V, Grubb A.

Acta Pathol Microbiol Immunol Scand A. 1987 Nov;95(6):357-63.

PMID:
3120491
11.

High frequency of amyloid lymphadenopathy in uremic patients.

Güz G, Ozdemir BH, Sezer S, Yakupoglu U, Demirhan B, Ozdemir FN, Haberal M.

Ren Fail. 2000;22(5):613-21.

PMID:
11041293
12.

Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study.

Ueda M, Horibata Y, Shono M, Misumi Y, Oshima T, Su Y, Tasaki M, Shinriki S, Kawahara S, Jono H, Obayashi K, Ogawa H, Ando Y.

Mod Pathol. 2011 Dec;24(12):1533-44. doi: 10.1038/modpathol.2011.117. Epub 2011 Aug 5.

13.

Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.

Sethi S, Theis JD, Leung N, Dispenzieri A, Nasr SH, Fidler ME, Cornell LD, Gamez JD, Vrana JA, Dogan A.

Clin J Am Soc Nephrol. 2010 Dec;5(12):2180-7. doi: 10.2215/CJN.02890310. Epub 2010 Sep 28.

14.

Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence.

Collins AB, Smith RN, Stone JR.

Cardiovasc Pathol. 2009 Jul-Aug;18(4):205-16. doi: 10.1016/j.carpath.2008.05.004. Epub 2008 Jul 11.

PMID:
18619857
15.

[Contribution of myocardial biopsy and immunohistochemistry to the prognostic evaluation of cardiac amyloidosis].

Van de Walle JP, Fourcade L, Panagides D, Harle JR, Pellissier JF, Touze JE, Bory M.

Arch Mal Coeur Vaiss. 1994 Feb;87(2):235-9. French.

PMID:
7802531
16.

Cardiac amyloidosis diagnosed by endomyocardial biopsy. Clinical, histopathological, immunohistochemical and ultrastructural studies.

Prochorec-Sobieszek M, Bilińska ZT, Grzybowski J, Michalak E, Jakubowska E, Sobieszczańska-Małek M, Deptuch T, Walczak E, Wagner T, Walski M, Rózański J, Kiedrowski M, Lubiszewska B, Hoffman P, Rózyłło W.

Kardiol Pol. 2005 Jul;63(7):20-35. English, Polish.

PMID:
16136426
17.

Biochemical characterisation of amyloid by endomyocardial biopsy.

Benson MD, Breall J, Cummings OW, Liepnieks JJ.

Amyloid. 2009 Mar;16(1):9-14. doi: 10.1080/13506120802676914.

PMID:
19291509
18.

Direct tissue evaluation via immunofluorescence: in the diagnosis of hereditary transthyretin cardiac amyloidosis.

Fradley MG, Thakuria JV, Collins AB, Moore SA, Stone JR.

Tex Heart Inst J. 2012;39(1):71-5.

19.

Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.

Biolo A, Ramamurthy S, Connors LH, O'Hara CJ, Meier-Ewert HK, Soo Hoo PT, Sawyer DB, Seldin DC, Sam F.

Circ Heart Fail. 2008 Nov;1(4):249-57. doi: 10.1161/CIRCHEARTFAILURE.108.788687. Epub 2008 Oct 14. Erratum in: Circ Heart Fail. 2009 May;2(3):e3. Seldin, David S [corrected to Seldin, David C].

20.

Immunoglobulin-related (AL) amyloidosis.

Husby G.

Clin Exp Rheumatol. 1983 Oct-Dec;1(4):353-8. Review.

PMID:
6442636
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk